Stock Events

Lineage Cell Therapeutics (LCTX) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.04
-0.04
-0.03
-0.03

Details

Expected EPS
-0.04
Actual EPS
-0.03
Surprise EPS
0.01
Surprise Percent
+25%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q4 2022.

0 Comments

Share your thoughts